You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In a study published last month, Mammoth demonstrated the technology's sensitivity, specificity, and speed compared to PCR-based COVID-19 testing.
French startup SeqOne has adapted its sequencing data-analysis platform to support a new method for high-throughput processing of coronavirus tests in its home country.
The German hospital will build interpretation and reporting on the PierianDx Clinical Genomics Workspace for two Illumina assays.
Lexogen did not disclose the funding amount, but said it was one of €16 million ($17.4 million) in awards from the Austria Research Promotion Agency.
Genomics England has slashed storage costs by migrating to a new file system, while NIH's All of Us research program is seeking savings from a cloud environment.
Illumina, LabCorp, and Providence healthcare will join the effort to collect COVID-19 patient samples in the US for immune cell receptor sequencing.
The deal is part of a wider collaboration between the companies to develop molecular diagnostic tests using their respective platforms.
Founded by former Inteliquet CEO Carla Balch, the firm is building on visualization technology to help physicians incorporate MDx testing into their practice.
The company recently inked deals with Mammoth Biosciences and Rutgers University to license a protein discovery platform and gene editing technology.
Italy's Dante Labs is building one of Europe's largest genomic labs and leading an effort to sequence 100,000 whole genomes around the Mediterranean.
President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.
CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.
A study of Great Danes homes in on a genomic region linked to fearfulness.
In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.